Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 98.40%
August 31, 2026 96.00%
July 31, 2026 96.00%
June 30, 2026 94.60%
May 31, 2026 89.20%
April 30, 2026 88.00%
March 31, 2026 88.00%
February 28, 2026 88.00%
January 31, 2026 88.00%
December 31, 2025 88.75%
November 30, 2025 88.75%
October 31, 2025 88.75%
September 30, 2025 88.75%
August 31, 2025 88.75%
July 31, 2025 90.62%
June 30, 2025 91.25%
May 31, 2025 95.19%
April 30, 2025 95.19%
March 31, 2025 95.19%
February 28, 2025 95.19%
January 31, 2025 95.19%
December 31, 2024 95.19%
November 30, 2024 95.19%
October 31, 2024 95.19%
September 30, 2024 95.19%
Date Value
August 31, 2024 95.19%
July 31, 2024 95.19%
June 30, 2024 95.56%
May 31, 2024 96.28%
April 30, 2024 96.28%
March 31, 2024 97.44%
February 29, 2024 97.44%
January 31, 2024 97.44%
December 31, 2023 97.44%
November 30, 2023 97.44%
October 31, 2023 97.44%
September 30, 2023 97.44%
August 31, 2023 97.44%
July 31, 2023 97.44%
June 30, 2023 97.44%
May 31, 2023 97.44%
April 30, 2023 97.44%
March 31, 2023 97.44%
February 28, 2023 97.44%
January 31, 2023 97.44%
December 31, 2022 97.44%
November 30, 2022 97.44%
October 31, 2022 97.44%
September 30, 2022 97.44%
August 31, 2022 97.44%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Windtree Therapeutics, Inc. 100.0%
Biostax Corp. 100.00%
GeneLink, Inc. 99.99%
Protokinetix, Inc. 99.93%
NovAccess Global, Inc. 100.00%